HAB Pharma merges Signature Phytochemicals, eyes Rs3,000 crore revenue by 2030HAB Pharma and Signature Phytochemicals have merged, creating a consolidated entity with a turnover of Rs600 crore. This strategic move aim...
What makes tires so tough has been a mystery for 100 years, scientists just found the surprising answerResearchers at the University of South Florida have uncovered the mechanism that makes reinforced rubber exceptionally strong, solving a sc...
Wealth creation is also about ignoring noise on the street: 15 mid- and small-cap stocks from different sectors which fit the billIn the April 2022-September 2024 bull market, every management appeared capable. Margins expanded, working capital looked manageable, capit...
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
Supreme court panel defines minimum ICU standards, outlines staffing norms and infrastructure requirementsThe Supreme Court has mandated minimum standards for ICUs, covering infrastructure, equipment, and staffing. States must submit action plan...
Syringe companies feel the pain as vaccination rate dipsProduction of AD immunisation syringes at its plants has fallen from 4.5-5.0 million units per day a year ago to 500,000-600,000 now. "We a...
Syringe companies told to defer supplies as vaccination slowsIn view of the current availability and estimated requirement of syringes for Covid-19 vaccination and Universal Immunisation Programme, it...
Quantitative restriction on export in place for certain syringe types for 3 months: Health ministryThe restriction applies to just three categories of syringes, it said and added that syringes are vital to sustain the momentum of the prog...
AiSMA expresses concerns over government’s decision to restrict syringe exportRajiv Nath, President, All India Syringes and Needles Manufacturers Association (AiSNMA) urged the government to lift the restriction on no...
Samsung importing 1 million syringes for Covid-19 vaccinationThe Low Dead Space (LDS) syringes minimize the amount of drug left in the syringes after an injection, reducing vaccine wastage, and thereb...
COVID-19: HMD to recruit 500 people to increase syringe production capacity"We currently have extreme shortages of manpower. To reach our target of 100 crore syringes capacity, HMD needs to strengthen our team and ...
On track to produce 177.6 million auto-disable syringes for government by March: HMD"The front runner COVID vaccines being launched in India would need a 0.5ml AD syringe for intramuscular drug delivery we are informed. In ...
Auto-disable syringes are the best option to prevent reuse: HS Ratti, epidemiologist"Companies making these syringes have large capacities. They should be able to supply the desired quantity. There are regular training prog...
Covid has given syringe makers an unparalleled opportunity. And a prickly problemSyringe manufacturers are hopeful of meeting the demand arising out of the upcoming Covid vaccination programme, but a lack of clarity on t...
In a first, syringe and needle manufacturers seek price capSyringes and needles are among the most commonly used devices which account for huge bills, and are being used by hospitals to fleece patie...
Domestic firms volunteer to drop syringe, needle prices over 50%According to an industry executive who did not wish to be named, the domestically manufactured syringes and needles market together is esti...
Hindustan Syringes to partner WHO for auto-disable syringesThe WHO campaign aims to completely eliminate the practice of using re-usable syringes and replace it with auto-disable (AD) syringes.